2025 Interim Meeting Ethics Forum — Ethics & CRISPR: Exploring the Moral, Ethical, and Policy Challenges Posed by Gene Editing Technology
Monday, December 8, 2025, 7:00-8:00 p.m. EST – Virtual Live Webinar
Activity Description
Ethics & CRISPR: Exploring the Moral, Ethical, and Policy Challenges Posed by Gene Editing Technology is designed to help clinicians, researchers, and healthcare professionals engage with one of the most transformative and controversial innovations
in modern medicine. This interactive session will explore the promise and perils of CRISPR through the lens of ethics and public policy. Participants will examine real-world scenarios, review current and emerging guidelines, and discuss strategies
for addressing the moral dilemmas raised by gene editing in clinical and research settings. By the end of this program, learners will gain the tools to critically evaluate the implications of CRISPR, counsel patients and families, and contribute meaningfully
to broader conversations about responsible innovation in healthcare.
Activity Objectives
Upon completion of this activity, learners should be able to:
-
Describe the scientific basis of CRISPR and its current and emerging applications in medicine.
-
Analyze the ethical, moral, and policy challenges associated with the use of gene editing technologies in clinical and research settings.
-
Evaluate case-based scenarios to apply ethical principles to real-world decisions in genetics, reproductive medicine, and public health.
-
Identify the role of clinicians, policymakers, and researchers in ensuring responsible use of CRISPR technologies.
Program Fees*
Massachusetts Medical Society (MMS) Physician Member – $95
MMS Resident/Student Member – Free
Non-Member Physician – $190
Allied Health Professional/Other – $75
*Click here for member educational voucher information
Faculty
Neal Baer, MD, MA, MEd
Co-Director, Harvard Medical School Master’s Degree Program in Media, Medicine, and Health
To learn more about Dr. Neal Baer, click here.
Accreditation Statement
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.
